School of Medicine

The School of Medicine has joined the Pediatric Heart Network, a multicenter collaboration of leading hospitals and research institutions that works to improve care for pediatric heart disease patients.

Gregory J. Zipfel, MD, head of the Department of Neurosurgery at the School of Medicine, has been awarded the Ralph G. Dacey Jr., MD, Medal for Outstanding Cerebrovascular Research.

Jennie H. Kwon, DO, an associate professor of medicine in infectious diseases, and Jason G. Newland, MD, a professor of pediatrics, both at the School of Medicine, have been selected to serve on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.

Washington University in St. Louis and Deerfield Management, a health-care investment firm, announced the launch of VeritaScience, a new private R&D collaboration designed to advance the discovery, clinical development and commercialization of promising therapeutic and diagnostic candidates with potential to benefit human health.

Three WashU researchers developing promising therapeutics for cancer and heart disease are the inaugural awardees of the Needleman Program for Innovation and Commercialization. The next round of project proposals is now open.

At the university’s Board of Trustees meeting Dec. 1, numerous faculty members were appointed or promoted with tenure or granted tenure.

Todd A. Fehniger, MD, PhD, and colleagues Alice Y. Zhou, MD, PhD, Ryan C. Fields, MD, and George Ansstas, MD, all at the School of Medicine, have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.

A new study from the School of Medicine identifies a key feedback loop between the brain and the fat tissue that governs aging in mice. The research suggests that the loop’s gradual deterioration contributes to health problems typical of aging.

Researchers at the School of Medicine found that metabolism-boosting, bile acid-reducing drugs improved gut health in mice. The findings indicate a new approach that may help malnourished children with stunted growth.

Researchers at the School of Medicine have determined how Eastern equine encephalitis virus attaches to a receptor it uses to enter and infect cells. The findings lay a foundation for treatments and vaccines for viral infections.